Mark Gu

My colleagues, Val Panier, together with John Wu, Nithya Vaduganathan, Vladimir Lukic, Margot Bleys, and in partnership with the Massachusetts High Technology Council, Inc. recently released a white paper outlining actionable recommendations to leverage AI for advancing the state’s life sciences and #healthcare sectors. The state of Massachusetts is making significant strides to become a leader in artificial intelligence. The potential for AI in healthcare is immense. Our report details a strategic approach to utilizing AI to improve patient outcomes, promote health equity, and accelerate breakthrough innovations. Learn more here: https://lnkd.in/em_EyTjw

67

2 Comments

BCG and Massachusetts High Technology Council–in collaboration with leaders from industry, hospitals, and academia–examine AI’s transformative potential in patient care and life sciences in a recent white paper. Read to learn how we plan to lead in applied #AI, focusing on better patient outcomes and groundbreaking innovations: https://on.bcg.com/3xqah2s

18

1 Comment

One conversation we should be having more, especially in healthcare: is this an AI problem or a policy problem? A big challenge in American healthcare stems from the reality that our healthcare strategy changes with every administration. Throwing AI at problems that are well-addressed by policy innovation (e.g., AI for payer-provider RCM war) feels like a gross misallocation of resources. Solution sets are rarely zero sum – in truth, most problems will require policy, tech, and human interventions, but it's worth asking ourselves whether AI is the best solve when we have a multitude of options.

86

22 Comments

What a day! I had a privilege to participate in a panel discussion moderated by the visionary Cheryl K Goodman and featuring my colleagues, industry leaders Jerome Bonhomme, Anil Keswani, MD, and Rangarajan Sampath. We delved into practical approaches to AI in health and biotech for the SoCal investor and startup community. Here are some key takeaways: - Move beyond isolated use cases and focus on transforming entire workflows within the business. - Prioritize AI solutions that address productivity and operational efficiency, freeing up resources to reinvest in top-line revenue generation. - Focus on enterprise LLMs to unlock the true value of generative AI in your organization using your own proprietary data. - Start with a robust AI governance framework before deployment, prioritizing data and model security. - AI-augmentation of the business is customer-centric. It's only good if it's useful to your employees and patients. TechCon SoCal #techconsocal2024 #AI #Healthcare #Biopharma #Innovation #Startups

78

7 Comments

BIG IDEAS IN TECH IN 2025. Check out what some of the most informed people at a16z Bio + Health think about where the tech is going in 2025. Vineeta Agarwala, MD PhD describes how Big is Back in Biotech - after an era of focus on rare diseases, we expect a swing back towards developing therapies to address bigger ticket, common disease areas such as #diabetes and #obesity. My BIG idea for 2025 is to use #AI to empower consumers, patients and providers with smart #digitaltherapeutics for digital #obesity care everywhere. We built an #AI #brain that combines the wisdom of the crowds and the wisdom of the experts. Her name is MIA. We just scratched the surface. We are a long way from building billions and billions of digital neurons that fire together and wire together. Everybody talked about GLP-1 drugs like #Ozempic, #Wegovy, #Mounjaro or #Zipbound in 2024. In 2025 it's time to talk about how to use smartphones, advanced biosensors, AI-driven #neurobehavioral digital therapies and #foodishealth to deliver programs that are preventive, precise, personalized, affordable and...scalable! That will truly improve access and delivery, reduce cost between 6X to 38X times relative to existing science-based solutions like behavioural therapists ($325/one session), meds ($800-$1,300/mo for life) or bariatric surgery (up to $23,000). Check out MYND Therapeutics Inc. Download #MYNDSET on the App Store right now! Let us know your BIG idea and where you think tech is going in the new year.

5

[GENERATIVE AI] The Wharton School professor Ethan Mollick says your team should bring generative AI into everything they do – right now (!!!). Ethan discusses what he’s learned through direct experimentation with AI, where he sees the most potential, and why organizations are struggling to create value with them - with Camila Nagano and Jacques Meir: https://lnkd.in/dKstZFAn

13

1 Comment

Healthcare IT has the potential to not only make healthcare more efficient but also revolutionize how we deliver care. In this episode of the Dry Powder podcast, my colleagues Hugh MacArthur and Eric Berger sit down with Adam Gale, cofounder and CEO of KLAS Research. Adam provides insights into his firm’s proprietary data on healthcare IT spending, exploring how providers are under pressure to demonstrate ROI and how emerging technologies could help a short-staffed industry regain stability. Listen to the full episode here. https://bit.ly/3BsY9zv

4

1 Comment

Thrilled to share Boston Consulting Group (BCG) has been named a leader in The Forrester Wave ™: AI Service Providers, Q2 2024💥. At BCG X and BCG, we’re proud to stand at the forefront of the #AI revolution helping our clients achieve transformative impact at scale. As Forrester states, “[BCG’s] vision stands out, focused on its clients becoming more competitive with AI while bringing notable clarity about the investments in areas such as R&D, technical development, talent quality, and sector-specific capabilities.” Read more about what we believe sets us apart: https://bit.ly/4ak5H2M #ArtificialIntelligence #AI #GenerativeAI #GenAI

34

What an amazing discussion! From regulations and implementation to finding news ways to utilize AI to save money, hyper scale your business and dominate your market, AI has tremendous potential if used judiciously. Gentreo @Alineaventures AuditMate

6

1 Comment

I have long admired Meredith Whittaker for her passionate, principled, and honest perspective on the impact of Big Tech on society. Her leadership as a founder of the AI Now Institute is only one example, and it was great to see her taking the helm at Signal in 2022. This WIRED interview with her is absolutely a must-read … “I know that tech done differently is possible. I don’t think it’s fair to say other alternative models just haven’t worked because people prefer Big Tech. No, these alternative models have not received the capital they need, the support they need. And they’ve been swimming upstream against a business model that opposes their success. “It’s not for lack of ideas or possibilities. It’s that we actually have to start taking seriously the shifts that are going to be required to do this thing—to build tech that rejects surveillance and centralized control—whose necessity is now obvious to everyone.” https://lnkd.in/gcvH-UCs #SurveillanceCapitalism #Privacy #BigTech #AI #Ethics

15

2 Comments

My colleagues, Eric Berger, Robbie Sandig, and KC George shares how large and small pharma companies are succeeding with generative AI and the three-tiered approach guiding them to the forefront. Key takeaways include the importance of priming operating models and leveraging scale for breakthroughs.

7

John Sviokla, co-founder of GAI Insight and HBS Executive Fellow, and Tom Davenport, Professor of IT and Management at Babson College, continue to provide thoughtful and practical guidance on generative AI! 🏆 Importantly, they consider the human, technical, financial, and political realities of companies today. 💎 They share six organizational disciples and capabilities needed for generative AI success. 💥 Companies without these disciplines face challenges in creating ongoing value from their generative AI experiments. Read more: https://lnkd.in/eSkXGY-D Paul Baier

18

3 Comments

Had a surprising and unique interaction tonight. It was at a dinner for AI founders and investors from the Boston area. Someone spoke about the differences between east coast and west coast VCs and said the MA government needed to spend more and the Boston area VCs needed to do a better job supporting companies (I think that was the point). They started by saying that the VCs on the panel added no value. (Maybe with an expletive in there too!) I raised my hand shared a slightly different view, that distinctions in regional investing would diminish as things became increasingly globalized (or at least nationalized, instead of metropolitan hubs) and that it’s not hard to reach out if you use zoom and are willing to fly (and have gotten term sheets and raised rounds from both coasts without it being too hard) After the panel (which was a good one and more engaging than many I’ve seen!) that person came up to me and asked if I was the guy who made that comment. When I confirmed I was, they matter of factoy (but with some intensity) said “You don’t have a f*%^ing clue what you’re talking about.” Hadn’t had an experience like that before, but I guess there’s a first time for everything! The happy ending to the story is 1) I was calm and polite (not sure that would’ve been my response in my 20’s!) and 2) After we talked a little about our backgrounds and the issues, the individual totally changed their approach and said some kind things and (I think) retracted their hostile view of me. Honestly I appreciated that they were willing to have bold, contrarian positions and share them publicly. Many are too afraid to do so and despite the “contrarian” reputations investors have, many just follow the herd and chase trends. Finding someone who thinks differently and is willing to publicly pursue a less common viewpoint (backed by deep experience) and risk personal capital is admirable. Just maybe with the f bombs. 😏

48

12 Comments

✨Generative AI is poised to transform nearly every aspect of the life sciences industry – but success at scale hinges on a clear gen AI strategy, dedicated budget, and custom solutions. In this new article, my McKinsey colleagues surveyed more than 100 pharmaceutical, biotech, and medical-device leaders to better understand their activity related to commercial applications of gen AI. Here are 4 insights they uncovered: ☑ At-scale adoption remains limited ☑ The early impact is promising ☑ Purposeful prioritization is a major differentiator ☑ Companies plan to build their own gen AI capabilities The biggest takeaway of all? Commercial life sciences leaders with a defined gen AI strategy and dedicated budgets were twice as likely to see meaningful results than those without them. Learn more here: https://lnkd.in/eK-vFgE3 #commerciallifesciences #lifesciences #genAI #innovation

9

✨Generative AI is poised to transform nearly every aspect of the life sciences industry – but success at scale hinges on a clear gen AI strategy, dedicated budget, and custom solutions. In this new article, my McKinsey colleagues surveyed more than 100 pharmaceutical, biotech, and medical-device leaders to better understand their activity related to commercial applications of gen AI. Here are 4 insights they uncovered: ☑ At-scale adoption remains limited ☑ The early impact is promising ☑ Purposeful prioritization is a major differentiator ☑ Companies plan to build their own gen AI capabilities The biggest takeaway of all? Commercial life sciences leaders with a defined gen AI strategy and dedicated budgets were twice as likely to see meaningful results than those without them. Learn more here: https://lnkd.in/eY77nrXS #commerciallifesciences #lifesciences #genAI #innovation

17

Last year I put together as comprehensive of a list as I could of every single active venture backed startup in Boston over the last 5+ years. Very useful exercise! ...very difficult to maintain. Friends of LinkedIn - do you know of a tool that can automatically & publicly update this table for me weekly to keep the people of Boston informed of their venture backed population? I will highlight the tool on the page to the hundreds (soon thousands) of people that view it every month! Link to the manual version here: https://lnkd.in/ek9wSfUD The AI should also be able to answer this question: Which weighs more? A pound of bricks or a pound of feathers? Happy Friday to you!

16

6 Comments

There is a huge demand for major capital projects coming from AI, renewables, manufacturing and general electrification - this article from Utility Dive highlights recent work from my colleagues on how to drive a step change in major capital project execution! #energytransition #Bain #majorcapitalprojects

3